Frankfurt
20.01.25
08:15 Uhr
0,173 Euro
-0,030
-14,98 %
-14,98 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,205 | 0,212 | 20.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.01. | SpineGuard Reports Its Full-Year 2024 Revenue | 282 | Business Wire | +8% growth globally, +20% in the US
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology... ► Artikel lesen | |
| 07.01. | SpineGuard Completes a Bond Financing to Support the Deployment of Its New Products | 696 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 06.01. | SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership | 228 | Business Wire | Scope of initial agreement extended to other products and countries Reallocation of personnel and resources to bolster the launch of Omnia products in the United States including PsiFGuard
Regulatory... ► Artikel lesen | |
| 03.01. | SpineGuard announces its 2025 financial calendar | 245 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 09.10.24 | SpineGuard Announces Its Q3 2024 Revenue | 395 | Business Wire | Growth acceleration to continue in Q3 2024: +20% globally and +30% in the US Revenue up +13% over the first 9 months, to €3.6 million
Regulatory News:
SpineGuard (FR0011464452 ALSGD)... ► Artikel lesen | |
| 30.09.24 | SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 383 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Key milestone for the deployment of the DSG technology in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
| SPINEGUARD Aktie jetzt für 0€ handeln | |||||
| 11.09.24 | SpineGuard Reports its H1 2024 Financial Results | 326 | Business Wire | Revenue growth by 10% at constant exchange rate Net loss reduced by 20% and EBITDA improved by 30%
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
| 03.09.24 | SpineGuard obtains EC-MDR certification and launches its Threaded PediGuard for anterior spine surgery in Europe | 446 | Business Wire | Regulatory News:
SpineGuard (Paris:ALSGD)(FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
| 17.07.24 | SpineGuard Files Its "510K" Dossier in the US for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 559 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Acceleration of commercial deployment of SpineGuard in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
| 15.07.24 | SpineGuard Announces its H1 2024 Revenue | 262 | Business Wire | Growth acceleration in Q2, +14% globally (+26% in the US) 10% growth at constant exchange rate in the first half
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company... ► Artikel lesen | |
| 26.06.24 | SpineGuard Reports on Its Annual Shareholders' Meeting of June 26, 2024 | 339 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 20.06.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.06.2024 | 526 | Xetra Newsboard | Das Instrument LPHG LU1834988351 LIF-600 PER.+H. EOA ETF wird cum Kapitalmassnahme gehandelt am 20.06.2024 und ex Kapitalmassnahme am 21.06.2024 The instrument LPHG LU1834988351 LIF-600 PER.+H. EOA... ► Artikel lesen | |
| 17.04.24 | SpineGuard Announces Its Full-Year 2023 Financial Results and Its First Quarter 2024 Sales | 417 | Business Wire | Innovation and US investment in 2023 1Q24 sales back to growth +6% globally, +23% in the US
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its... ► Artikel lesen | |
| 05.03.24 | SpineGuard Reaches a Significant Regulatory Milestone to Strenghthen its PediGuard Offering in China | 438 | Business Wire | Submission of a file to the Chinese authorities (NMPA) to obtain renewed approval for the currently available range of PediGuard in China, as well as its extension to add the Curved and XS PediGuard... ► Artikel lesen | |
| 06.02.24 | SpineGuard Reaches the Milestone of 100,000 Surgeries and Over 30 Publications With DSG Technology | 471 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) unique sensing technology using electrical conductivity local measurement... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 36,380 | +0,22 % | Leichte Zugewinne bei der Fresenius SE & Co. KGaA-Aktie (36,58 €) | Das Wertpapier von Fresenius SE & Co. KGaA notiert heute fester. Der jüngste Kurs betrug 36,58 Euro. Die Fresenius+Co KgaA-Aktie verzeichnet gegenwärtig einen Wertanstieg von 2,75 Prozent. Sie hat sich... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,10 | -0,08 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 53 Euro auf "Neutral" belassen. Im europäischen Medizintechnik-Bereich gebe... ► Artikel lesen | |
| TELADOC HEALTH | 8,681 | -0,99 % | Amazon Adds Teladoc Health to Health Benefits Program | ||
| THERMO FISHER | 536,50 | +0,28 % | MedMira mit zweiter Zulassung!: MedMira erhält von Health Canada Zulassung für Reveal® G4 Rapid HIV-1/2 Test | ||
| EUROFINS SCIENTIFIC | 47,780 | -0,08 % | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 December 2024 | Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 December 2024 ANNEXE B Form to... ► Artikel lesen | |
| SYNLAB | 11,280 | 0,00 % | UNGLAUBLICHE Sondermeldung bei Synlab Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
| DAVITA | 162,55 | 0,00 % | DaVita Earnings Preview: What to Expect | ||
| SPINEWAY | 0,100 | -15,61 % | Spineway wins new approvals in Vietnam and registers initial orders | Press release Ecully, December 18, 2024 - 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment... ► Artikel lesen | |
| DENTSPLY SIRONA | 18,070 | -0,11 % | Dentsply Sirona Plans To Redefine Byte Business Model | YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona (XRAY) said it plans to refocus the Byte business model around treatments that include expanded in-person dentist oversight. The company is evaluating... ► Artikel lesen | |
| SMITH & NEPHEW | 12,280 | +0,45 % | Smith & Nephew UK Ltd: Smith+Nephew's ALLEVYN LIFE Sacrum Foam Dressing and LEAF Patient Monitoring System receive 'favorable' Evidence Bar ratings from ECRI for pressure injury prevention | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI - leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence... ► Artikel lesen | |
| SONIC HEALTHCARE | 16,500 | +0,22 % | Dividendenbekanntmachungen (04.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEGON LTD BMG0112X1056 - 0,16 EUR AUTOLIV INC US0528001094 0,68 USD 0,6156 EUR AVERY DENNISON CORP US0536111091 0,88 USD 0,7967... ► Artikel lesen | |
| EMPOWER CLINICS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.07.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 30.07.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.07.2024ISIN NameCA29246V2030 EMPOWER... ► Artikel lesen | |
| ONTRAK | 1,710 | +0,59 % | Ontrak Inc. (OTRK): AI-Powered Healthcare Solutions Under $2 Billion | ||
| DIASORIN | 101,10 | -0,74 % | Earnings call: DiaSorin reports growth and raises 2024 guidance | ||
| PATTERSON COMPANIES | 30,200 | +1,34 % | XFRA PD2: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
SPINEGUARD SA gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,173 Euro und damit -14,98 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SPINEGUARD SA finden Sie auf Wallstreet Online.
